Ceros Capital Markets
Overview
Ceros Capital Markets specializes in fundraising (primarily Series A-D) for MedTech companies that are developing disruptive technologies, particularly for diagnostic and non-invasive procedures in the medical device, robotic, biotech, and digital health sectors . Ceros clients have the opportunity to invest in companies that are pushing the boundaries of technology, disrupting the medical industry, and fueling innovation to help change lives .
Portfolio Companies
11
Website
cerosfs.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cordio Medical | Jan 2024 | SAFE | Co-investor |
| GT Metabolic Solutions | Nov 2023 | Series B | Co-investor |
| Wesper | Nov 2022 | Series A | - |
| GT Metabolic Solutions | Jul 2022 | Series A | Lead |
| Cordio Medical | Jun 2022 | Series C | Lead |
Key People
Andrew Massaro
Junior Partner
CRCP® Daniel Wilson
Communications Principal AML Officer
David Styfco
Registered Principal
Eric Hilderbrand
Registered Principal
Manuel Klemm
Licensing Principal
Chris Dewey
Partner, Venture Capital Markets
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
